BioMarin Pharmaceutical Inc. (BMRN)

BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11,049	12,527	18,162	19,234	16,220	15,918
Market Cap Growth	-32.56%	-31.03%	-5.57%	18.57%	1.90%	4.81%
Enterprise Value	10,182	12,199	18,132	19,051	16,229	15,917
Last Close Price	58.00	65.73	96.42	103.49	88.35	87.69
PE Ratio	16.93	29.35	108.34	135.87	-	18.64
Forward PE	13.29	17.86	38.98	39.00	85.79	75.56
PS Ratio	3.62	4.39	7.51	9.18	8.79	8.56
PB Ratio	1.85	2.21	3.67	4.18	3.80	3.88
P/TBV Ratio	1.97	2.44	4.10	4.73	4.41	4.56
P/FCF Ratio	15.84	25.70	290.28	350.06	77.63	-
P/OCF Ratio	14.36	21.87	114.04	109.34	53.26	186.47
PEG Ratio	0.74	0.72	1.07	0.86	2.66	1.75
EV/Sales Ratio	3.32	4.28	7.50	9.09	8.79	8.56
EV/EBITDA Ratio	10.66	18.30	62.49	121.62	481.22	1186.81
EV/EBIT Ratio	11.68	21.40	97.60	348.42	-	-
EV/FCF Ratio	14.65	25.03	289.80	346.74	77.67	-
Debt / Equity Ratio	0.10	0.11	0.23	0.24	0.26	0.28
Debt / EBITDA Ratio	0.62	0.93	3.73	6.58	23.56	43.10
Debt / FCF Ratio	0.87	1.30	18.12	20.38	5.38	-
Asset Turnover	0.42	0.41	0.37	0.34	0.31	0.35
Inventory Turnover	0.44	0.50	0.53	0.60	1.49	1.67
Quick Ratio	3.34	2.96	1.45	2.98	2.54	3.07
Current Ratio	5.56	5.33	2.51	4.67	4.16	4.76
Return on Equity (ROE)	11.62%	8.05%	3.51%	3.19%	-1.53%	23.63%
Return on Assets (ROA)	7.50%	5.15%	1.76%	0.55%	-0.78%	-1.09%
Return on Capital (ROIC)	8.37%	5.76%	1.97%	0.61%	-0.87%	-1.24%
Return on Capital Employed (ROCE)	12.90%	8.90%	3.30%	0.90%	-	-
Earnings Yield	5.97%	3.41%	0.92%	0.74%	-0.40%	5.37%
FCF Yield	6.31%	3.89%	0.34%	0.29%	1.29%	-0.18%
Buyback Yield / Dilution	-0.35%	-2.67%	-1.39%	-3.34%	4.61%	-7.06%

Updated Aug 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q